Daiwa Securities Group’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
Other funds holding ROIV
Daiwa Securities Group's ROIV Position: Q3 2026 in Review
Daiwa Securities Group increased its Roivant Sciences (ROIV) stake by 33% in Q3 2026, buying an estimated $14M and bringing the position to 1,551,480 shares worth $56.7M. The position accounts for 0.11% of the portfolio, ranked #121.
Daiwa Securities Group first reported a position in ROIV in Q3 2022 and has held it in 17 quarters since. 141 funds tracked by Wall St. Rank hold ROIV as of Q3 2026.
- Daiwa Securities Group held 1,551,480 shares of Roivant Sciences worth $56.7M as of Q3 2026.
- Daiwa Securities Group bought 385,160 Roivant Sciences shares in Q3 2026, an estimated $14M.
- Roivant Sciences made up 0.11% of Daiwa Securities Group's portfolio in Q3 2026, its #121 holding.
- Daiwa Securities Group first reported a position in Roivant Sciences in Q3 2022 and has held it in 17 quarters since.
- 141 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2026.
Based on Daiwa Securities Group's 13F filing for Q3 2026, filed 29 Oct 2026.